Roberta Gualtierotti: rFVIIIFc and rFIXFc Ensured Effective Haemostasis and Favourable Safety in Major Orthopaedic Surgery
Roberta Gualtierotti, Associate Professor of Internal Medicine at University of Milan, shared on LinkedIn:
”Fc-fusion factors in orthopaedic surgery for haemophilia
Happy to share our experience at the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Ospedale Policlinico di Milano, Università degli Studi di Milano, and Florence Hemophilia Center, Azienda Ospedaliero-Universitaria Careggi.
Prospective study (2018–2023) on 20 major surgeries in 19 patients with haemophilia A or B treated with rFVIIIFc or rFIXFc.
- Haemostasis rated ‘good’ in 95% of cases
- No transfusions required
- No treatment-related adverse events
- we need more date to standardize and personalize perioperative schedule with EHL factors
Conclusion: rFVIIIFc and rFIXFc ensured effective haemostasis and favourable safety in major orthopaedic surgery.”
Title: Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half-Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective Study
Authors: Luigi Piero Solimeno, Roberta Gualtierotti, Emanuele Guido, Jacopo Acquati Lozej, Enrica Cristini, Alessandro Ciavarella, Sara Arcudi, Christian Carulli, Lisa Pieri, Simona Maria Siboni, Flora Peyvandi
Read the full paper here.
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Oct 9, 2026, 23:59Ana Pedrero Gil: Is Coagulopathy with Fibrinolysis Present in All Obstetric Hemorrhages?
-
Oct 9, 2026, 23:57Exploring the Psychosocial Needs of People with Bleeding Disorders in Kyrgyzstan – EAHAD
-
Oct 9, 2026, 23:53Bernard Slater Jr.: Serving on the Advisory Council for the NBDF West Virginia Chapter
-
Oct 9, 2026, 23:53Aurelio Maggio: Thalassemia Reports Real-Time Impact Factor Rises to 1.760
-
Oct 9, 2026, 23:52Stronger Connections, Stronger Organizations – World Federation of Hemophilia
-
Oct 9, 2026, 23:46Samuel Misiani Mbunya: Advancing Sickle Cell Care Through Collaboration at the 21st ASCAT Conference
-
Oct 9, 2026, 23:42Hadeel Swed: My First First-Author Publication in Thrombosis Research
-
Oct 9, 2026, 23:38Micheal Avoseh: Exploring Nanoparticle-Based Therapies for Thrombosis and Vascular Inflammation
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation